Data as of Jul 24
| +0.08 / +2.58%|
The 6 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 8.50, with a high estimate of 14.00 and a low estimate of 4.25. The median estimate represents a +167.30% increase from the last price of 3.18.
The current consensus among 6 polled investment analysts is to Buy stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.